MedTrace Logo

iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers

NCT02225301 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35000

Last updated 2026-01-26

No results posted yet for this study

Summary

Phase 1 was a randomized control trial that used a test-retest model to evaluate the impact of iLook Out for Child Abuse, an online, interactive learning module about reporting suspected child abuse. Delivered via a learning management system to early childhood professionals who work with infants and young children, this study assessed iLookOut's effect on 1) knowledge about reporting suspected child abuse; 2) attitudes toward reporting suspected child abuse; and 3) preparedness to protect children at risk.

Findings from Phase 1 were that iLookOut will improved knowledge, changed attitudes, and increase self-reported preparedness of early childhood providers to report suspected child abuse.

Phase 2 of this trial is an open-enrollment study that records pre-/post- data on the same measurements as Phase 1, and is available for use (free of charge) for all childcare providers in Pennsylvania at https://www.ilookoutforchildabuse.com.

Conditions

  • Child Abuse
  • Child Neglect
  • Child Maltreatment

Interventions

OTHER

iLook Out for Child Abuse

The online learning module is an interactive, multi-media, self-paced intervention.

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Benjamin H Levi, MD PhD · Penn State Milton S. Hershey Medical Center / Penn State College of Medicine

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02225301 on ClinicalTrials.gov